Constellation Brands, Inc. (STZ) Stock Forecast
Data as of Jul 31, 2026Consumer Defensive · Current price $130.04 (-0.18%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 10, 2026 | Gerald Pascarelli | Needham | $185.00 | +42.3% |
| Apr 10, 2026 | Chris Carey | Wells Fargo | $185.00 | +42.3% |
| Jan 9, 2026 | Andrew Strelzik | BMO Capital | $190.00 | +46.1% |
| Jan 9, 2026 | Peter Grom | UBS | $168.00 | +29.2% |
| Jan 5, 2026 | Bonnie Herzog | Wells Fargo | $160.00 | +23.0% |
| Nov 21, 2025 | Michael Lavery | Piper Sandler | $135.00 | +3.8% |
| Oct 8, 2025 | Gerald Pascarelli | Needham | $180.00 | +38.4% |
| Sep 3, 2025 | William Kirk | Roth Capital | $209.00 | +60.7% |
| Sep 3, 2025 | Chris Carey | Wells Fargo | $170.00 | +30.7% |
| Jun 27, 2025 | Boonie Herzog | Goldman Sachs | $225.00 | +73.0% |
| Jun 26, 2025 | Lauren Lieberman | Barclays | $202.00 | +55.3% |
| Jun 25, 2025 | Peter Grom | UBS | $195.00 | +50.0% |
| May 7, 2025 | Bill Chappell | Truist Financial | $215.00 | +65.3% |
| Feb 27, 2025 | Dara Mohsenian | Morgan Stanley | $202.00 | +55.3% |
| Oct 15, 2024 | Andrew Strelzik | BMO Capital | $305.00 | +134.5% |
| Oct 4, 2024 | Lauren Lieberman | Barclays | $300.00 | +130.7% |
| Oct 4, 2024 | Sorabh Daga | HSBC | $285.00 | +119.2% |
| Oct 4, 2024 | William Kirk | Roth Capital | $298.00 | +129.2% |
| Oct 4, 2024 | Robert Ottenstein | Evercore ISI | $300.00 | +130.7% |
| Oct 4, 2024 | Bill Chappell | Truist Financial | $255.00 | +96.1% |
Top Analysts Covering STZ
STZ vs Sector & Market
| Metric | STZ | Consumer Defensive Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.60 | 2.56 | 2.42 |
| Analyst Count | 35 | 10 | 19 |
| Target Upside | +26.7% | +1206.6% | +18.0% |
| P/E Ratio | 13.56 | 11.41 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-28 | $2.51B | $2.58B | $2.62B | 7 |
| 2026-08-30 | $2.48B | $2.58B | $2.75B | 6 |
| 2026-11-28 | $2.17B | $2.25B | $2.36B | 6 |
| 2026-11-30 | $2.17B | $2.25B | $2.41B | 4 |
| 2027-02-28 | $9.01B | $9.11B | $9.24B | 15 |
| 2027-05-28 | $2.42B | $2.47B | $2.53B | 8 |
| 2027-05-30 | $2.33B | $2.43B | $2.59B | 4 |
| 2027-08-28 | $2.52B | $2.57B | $2.63B | 8 |
| 2027-08-30 | $2.49B | $2.59B | $2.77B | 6 |
| 2027-11-28 | $2.23B | $2.28B | $2.33B | 8 |
| 2027-11-30 | $2.21B | $2.30B | $2.45B | 4 |
| 2028-02-28 | $1.91B | $1.95B | $2.00B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-28 | $3.50 | $3.79 | $3.97 | 10 |
| 2026-08-30 | $3.69 | $3.88 | $4.23 | 4 |
| 2026-11-28 | $2.87 | $3.00 | $3.19 | 7 |
| 2026-11-30 | $2.94 | $3.09 | $3.36 | 4 |
| 2027-02-28 | $11.54 | $11.83 | $12.38 | 13 |
| 2027-05-28 | $3.36 | $3.45 | $3.56 | 7 |
| 2027-05-30 | $3.26 | $3.43 | $3.73 | 4 |
| 2027-08-28 | $3.76 | $3.87 | $3.99 | 7 |
| 2027-08-30 | $3.72 | $3.92 | $4.26 | 4 |
| 2027-11-28 | $3.04 | $3.13 | $3.23 | 7 |
| 2027-11-30 | $3.14 | $3.31 | $3.60 | 4 |
| 2028-02-28 | $1.94 | $2.00 | $2.06 | 6 |
Frequently Asked Questions
What is the analyst consensus for STZ?
The consensus among 35 analysts covering Constellation Brands, Inc. (STZ) is Hold with an average price target of $168.73.
What is the highest price target for STZ?
The highest price target for STZ is $335.00, set by Garrett Nelson at CFRA on 2024-07-03.
What is the lowest price target for STZ?
The lowest price target for STZ is $135.00, set by Michael Lavery at Piper Sandler on 2025-11-21.
How many analysts cover STZ?
35 analysts have issued ratings for Constellation Brands, Inc. in the past 12 months.
Is STZ a buy or sell right now?
Based on 35 analyst ratings, STZ has a consensus rating of Hold (2.60/5) with a +26.7% upside to the consensus target of $168.73.
What are the earnings estimates for STZ?
Analysts estimate STZ will report EPS of $3.79 for the period ending 2026-08-28, with revenue estimated at $2.58B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.